We have analyzed the nucleotide sequences of 19 e V.5 transcripts derived from in vivo isotype switched peripheral blood B cells of three patients with atopic dermatitis. Comparison with the patients' own germline V.5 gene segments revealed that the e transcripts were derived from both functional members of the human V.5 gene family and harbored numerous somatic mutations (range 5-36 per V.5 gene). In two patients, we detected clonally related but diverged transcripts, permitting the construction of a genealogical tree in one patient. We observed a high proportion of shared silent (S) and replacement (R) mutations among e V.5 sequences derived from all three individuals, even among transcripts descending from the two different germline V.5 gene segments. A remarkably high number of these mutations is shared with previously reported V~5 genes encoding antibodies with defined specificities. The shared S mutations, and likely a fraction of the R mutations, appear to mark preferential sites ("hot spots") of somatic hypermutations in human V.5 genes. The distribution of R and S mutations over complementarity determining region and framework regions in the majority of V. regions deviated from that characteristic of antigen-driven immune response. We hypothesize that the V regions of immunoglobulin E-bearing B cells have accumulated "selectively neutral" mutations over extended periods of clonal expansion, resulting in unusual R/S ratios. We propose that the molecular characteristics of the e V. regions in atopic dermatitis may be representative of antigens that recurrently or chronically stimulate the immune system. opic dermatitis is an inflammatory skin disorder characterized by a chronically relapsing course with frequent exacerbations and a distinctive clinical morphology. Although the primary cause of atopic dermatitis is unknown, substantial evidence suggests that excessive production of IgE antibodies likely contributes to the pathogenesis of this disorder (1, 2). These antibodies are reactive with a wide variety of environmental allergens. The regulatory effects of allergenreactive T lymphocytes and their lymphokine products appear to be a major cause of the high serum levels of IgE in patients with atopic dermatitis (3-5).
opic dermatitis is an inflammatory skin disorder characterized by a chronically relapsing course with frequent exacerbations and a distinctive clinical morphology. Although the primary cause of atopic dermatitis is unknown, substantial evidence suggests that excessive production of IgE antibodies likely contributes to the pathogenesis of this disorder (1, 2) . These antibodies are reactive with a wide variety of environmental allergens. The regulatory effects of allergenreactive T lymphocytes and their lymphokine products appear to be a major cause of the high serum levels of IgE in patients with atopic dermatitis (3) (4) (5) .
Although the role of alhrgen-reactive T cells in controlling IgE class switching is beginning to be elucidated, little is known about the B lymphocytes that are recruited into the IgE response. In particular, questions related to the Ig gene segments encoding the V regions of IgE antibodies and the role of somatic hypermutation in the donal evolution of IgE responses have not been addressed. Similar studies on the molecular origin of human (anto)antibodies have largely depended on hybridoma technology and EBV transformation to generate monoclonal B cell lines secreting relevant specificities. Attempts to immortalize B lymphocytes switched to IgE in vivo have generally been unsuccessful.
In the present study we have employed a cDNA/PCR approach to analyze the molecular structure of V regions expressed in IgE antibodies of atopic dermatitis patients. This strategy permitted the selective amplification of e V. region transcripts from RNA extracted from PBMC. Our data show that members of the V.3-V.6 gene families may be utilized in IgE antibodies from patients with atopic dermatitis. The small human V.5 gene family, which contains only two functional members, was abundantly expressed in e transcripts.
Comparison of the nucleotide sequences of 19 e V.5 transcripts with the germline V.5 genes of these patients revealed the accumulation of high numbers of somatic mutations. A surprisingly high proportion of silent (S) 1 and 1 Abbreviations used in thispaper: FR., framework; R, rephcement mutation; replacement (R) mutations was shared among sequences derived from different members of the V~5 gene family, In two patients, we detected evidence for transcripts derived from clonally related but diverged IgE-bearing B cells which, in one patient, permitted the construction of a genealogical tree. The results of these experiments are discussed in the context of the molecular mechanisms contributing to a dinicaUy relevant IgE-mediated chronic immune response.
Materials and Methods
Patients. All patients analyzed suffered from severe atopic dermatitis according to the diagnostic criteria formulated by Hanifin et al. (6) . Patient Pl is a female adult with a total serum IgE level of 18 x 103 kU/liter. Patient P2 is a 12-yr-old boy with a total serum IgE level of 5.3 x 103 kU/liter, and patient P3 is a 9-yrold boy with an IgE serum level of 9.9 x 103 KU/liter. IgE in the serum of all three patients reacted with more than 15 different environmental allergens as detected in Radio Allergosorbent Test (RAST).
DNA and RNA Isolation. PBMC from atopic dermatitis patients were isolated by Ficoll-Hypaque density gradient centrifugation. Total cellular RNA was prepared from 2 x 10 e PBMC using RNAzoF M (Cinna/biotecx, Friendwood, TX) as described previously (7) . EBV-transformed polyclonal B cell lines were generated from 5 x 106 PBMC, and genomic DNA was isolated from 106 EBV-transfurmed B cells as detailed elsewhere (8) .
First-strand eDNA Synthesis and PCR. Total RNA was used as a template for first-strand cDNA with an oligoprimer specific for the first exon of the e constant region (Ce, 5'-TGTCCCGTT-GAGGGAG CCTGT-3') and 10 U of avian myeloblastosis virus (AMV) reverse transcriptase (Pharmacia, Uppsala, Sweden), according to standard procedures (7) . One tenth of the cDNA reaction mixture was amplified in a PCR employing a previously described set of 5' primers specific for the human V.3, V,4, V,5, and V~6 gene families (9) , in combination with a second, nested 3' Ce-specific primer containing a SalI restriction site (5'-GGG-TCGACAGTCACGGAGGTGGCATT-3'). Genomic DNA was amplified with the 5' V~5-specific primer and a 3' primer 100% homologous to sequences in the 3' flanking region of both functional VH5 genes (5'-GGGTCGACGGC~TC~TGG T-3 (10). All PCR reaction mixtures contained 200 ng of each primer and 2.5 U Taq polymerase (Promega Biotec, Madison, WI). Amplifications were performed in a Bioexcellence thermal cycler (Biores., Woerden, The Netherlands) and consisted of 35 cycles of 1 min denaturation at 94~ 1.5 rain primer annealing at 65~ and 1.5 rain extension at 72~ After the last cycle, reaction mixtures were incubated for 10 min at 72~ to ensure complete extension of all products.
Cloning and Sequencing of PCR-amplified Material. PCR-amplified material was digested with restriction enzymes EcoRI and SalI (Pharmacia) and separated on a 0.8% low-malting agarose gel (Nusieve; FML Bioproducts, Rockland, ME). A fragment of ~450 bp was excised and ligated into Bluescript (Stratagene Inc., La Jolla, CA) using standard procedures (7) . After transformation of competent D~5c, cells, colonies were transferred to nitrocellulose and screened with a 32P-labeled V~5 probe (11) . DNA sequence anal-),sis was according to Sanger et al. (12) using the T7 sequencing kit (Pharmacia).
Results
II. Gene Famil2/ Utilization in e V.5 Transcripts.from Atopic Dermat/tis Pat/ents, Total RNA extracted from PBMC of three patients with atopic dermatitis was extended with a Ce-specific primer and AMV reverse transcriptase, and first-strand cDNA was amplified by PCR using a nested Ce-specific primer in combination with 5' primers specific for the human VH3--VH6 gene families. All four V. primers yielded amplified PCR products of the expected size. The identity of PCR products was confirmed by hybridizing Southern blots of amplified material with 32p-labded V. gene family-specific probes, indicating the VH gene family specificity of all V~ primers used. The results demonstrated that e transcripts encoded by members of the human V.3-V.5 gene families were present in three atopic dermatitis patients, whereas V.6-encoded e transcripts were found in patient P3 only (data not shown). We were unable to amplify e V. transcripts from PBMC of four nonatopic, healthy donors.
Molecular Analysis of Germline V.5 Gene in Atopic Dermatitis Patients. In all three patients, we obtained abundant PCR products with the V.5 gene family-specific primer. The human V.5 gene family consists of only two functional members both of which are extremely well-conserved in the human population (10) . We focused on this gene family to analyze the molecular structure of e VH5 gene transcripts.
To that end, we first determined the nudeotide sequences of V.5 genes present in the germline of these patients. Genomic DNA from polyclonal, EBV-transformed B lines was used as starting material in PCR reactions employing primers specific for the leader and 3' end flanking sequences of both functional V.5 genes. For each patient, a minimum of 10 bacterial colonies hybridizing to a V.5 probe were randomly picked and used for nucleotide sequencing. In the genome of each patient, the two functional members of the V.5 gene family were detected, and no other V. family members or fragments were detected in this sequence analysis. In patients Pl and P2, both members displayed 100% sequence identity to the published germline genes (represented by the sequences of the V.5-1R1 and V.5-2R1 rearrangements [11] ). In patient P3, we detected a single nudeotide difference in one of the V.5-1R1 alleles (see legend to Fig.  I ). Based on the large number of germline V.5 genes sequenced, we estimate the PCR-induced error frequency to be <1/1200 in 35 cycles.
Inter-and Intraclonal Somatic Mutations in e V.5 Transcripts. To investigate the molecular structure of e V.5 regions, first-strand cDNA was synthesized from total RNA of PBMC and subsequently amplified in the PCR using a Ce and VHS-specific primer pair. PCR-amplified material was cloned into Bluescript vector and after transformation, multiple VHS-hybridizing colonies were used for nucleotide sequence analysis. AU 19 nudeotide sequences contained open reading frames and were derived from e V.5 transcripts, confirming the specificity of the Ce and V.5 primers. In Figs. 1 and 2 , we have compared the nucleotide and deduced amino acid sequences of the expressed and germline V.5 genes of patients Pl, P2, and P3. Table 1 summarizes the distribution of R and S mutations over framework and CDR regions. In this analysis, we excluded somatic mutations occurling in the junctional region, because the patient's germ-line diversity (D.) and joining (J.) gene segments were not available for comparison.
cDNA clones VHP2-57 and VHP1-58 derive from the germline V.5-2R1 gene, whereas the other 17 cDNA clones descend from the germline V,5-1R1 gene. All e V,5 sequences contain somatic mutations, ranging from 6 to 37 in the V, portion of individual transcripts. Close inspection of sequences from patient P2 reveals that nudeotide sequences P2-51, P2-52, P2-53, and P2-54 are not identical (between 95.7 and 99.2% sequence homology) but utilize the same D, and J. gene segments and are indistinguishable at the V~/D. and D,/JHjunctions (Fig. 1 ). This strongly suggests that the corresponding B cell clones are the progeny of a common precursor (13) . By the same criteria, the collection of eight sequences from patient P1 contains two donally related IgE transcripts, P1-54 and P1-57, that differ by four nucleotides in the V, segment (Fig. 1) .
Comparison of the nudeotide sequences of all e V.5 transcripts revealed that numerous mutations are shared among clonally related and unrelated sequences within one individual and among individuals. These shared mutations are present in both CDR and framework (FR) regions and are silent or result in amino acid replacements. Among the most extreme examples are mutations that occur in multiple independent e transcripts derived from all three donors (e.g., compare the C-~T substitution at position 173, the G-~A at position 230, and the C~T substitution at position 180). It is notable that these mutations involve descendants from both the V.5-1R1 and V.5-2R1 germline gene segments.
Based on the four donally related e V.5 sequences from patient P2, we constructed a genealogical tree that shows the nature and reconstructs the likely order of somatic mutations that occurred during expansion of this B cell clone (Fig. 3) .
The tree has been constructed to require the lowest number of parallel mutations. A total of 14 mutations (six R and seven S mutations) is shared by all four sequences. At the first branchpoint, four mutations are shared by clones P2-52 and P2-53 (three R and one S mutation). These clones differ from each other by four R and one S mutation. Similarly, clone P2-54 and P2-51 share four R and two S mutations and differ from each other by one S and one R mutation. 19, and. [, Gene Utilization. All J~ gene segments except J.2 were present in the e transcripts. The D.-gene segments were defined as the nudeotide sequences between the V.-and Jwgenes, and include putative N insertions. The D. segments varied extensively in nucleotide sequence and length and displayed partial sequence homology with previously published germline or expressed D. elements (Fig. 4) .
Discussion
Antibody diversity is generated through a number of mechanisms including somatic assembly and imprecise joining of multiple gene segments, combinatory assortment of different Ig H and L chains, and somatic hypermutation. Although the genetic mechanisms of antibody diversity are fairly wdl understood, little is known about their contribution to the human antibody response to clinically relevant exogenous antigens. We have analyzed Ig e VH gene transcripts from peripheral blood B cells of three patients with atopic dermatitis. The sera of these patients contained IgE antibodies reactive with at least 15 different environmental allergens. Our inability to amplify e transcripts from peripheral blood B cells of nonatopic individuals strongly suggests that these e V. transcripts were relevant to the allergic immune response. The results demonstrate that members of all human V, gene For each E transcript, the total number of mutations (columns 2 and 7), the R/S ratio in the overall V.5 region (columns 3 and 8), the CDR region (columns 4 and 9) and the FR regions (columns 5 and 10) are depicted. GCC  GAG  GTG  CAG  CTG  GTG  CAG  TCT  GGA  GCA  GAG  GTG  AAA  AAG  CCC  GGG  GAG  TCT  CTG  AAG  ATC  TCC  TGT  AAG  GGT I   TAT  CCT  GGT  GAC  TCT  GAT  ACC  AGA  TAC  AGC  CCG  TCC  TTC  CAA  GGC  CAG  GTC  ACC  AT(2 TCA  GCC  GAC  AAG  TCC  ATC GTC CGG  TTA GTT CCA GAT  GAT GAC GAC CAG  GAC TAC GGT GAC  GAC TAC GGT GAC   AGG GGG TCG GGG  AGG GGG TCG GGG  AGG GGG TCG GGG  AGG GGG TCG GGG  GGC CTT CAT GGG  GGT GAC TAC CAA TCC ACG GGG GGC  TAC CAA TCC ACG GGG GGC   ACT TAT TAT AGT GG  ACT TAT TAT ACT GG  ACT TAT TAT ACT GG  ACT TAT TAT ACT GO  ACC TCC TTC TCA AGC TG  AGA TAC TTC CGT GAT CCC   TAT TAT GGT TCG  GAC  ACC AAC TAC  CAC AGT TCC GCT   AAC TCG  GGT GGT ACC TGC   GGG AGT TCT GAC TAC TAC TAT TAC   GGG TGG TAT TAT CAG   TAT TCC GAA GCT AAA TCG Figure 3 . Genealogical tree ofclonaUy rehted transcripts from patient P2. This tree was constructed to require the fewest independent parallel replacements. Single-letter amino add code is used to denote R mutations.
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to reflect a process of positive selection by antigen. The R/S ratios in the CDR and FK regions of the e V.5 transcripts do not exhibit a consistent pattern (Table 1) . In fact, all combinations of high and low R/S ratios in FK regions with high and low K/S ratios in CDR regions occur (Table 1) . tion process. Several explanations, not mutually exclusive, for the heterogeneous R/S patterns in e V.5 transcripts are conceivable. The FR regions, especially FR3, may contribute to antigen binding, as has been argued on the basis of experimental data and theoretical considerations (18) (19) (20) (21) . In this respect, it is important to realize that antigen determines the shape of the antigen-binding portion of V regions and that current concepts concerning R/S distributions have largely been derived from analysis involving immunization with haptenic groups. The antigen combining site of hapten-binding antibodies may differ profoundly from that of protein-binding antibodies. Examples of nonhaptenic immune responses generating high affinity antibodies with "aberrant" R/S mutations have been reported in the literature (22) (23) (24) . An alternative interpretation is an extension of a model proposed by Manser (25) . It may be envisaged that initially, somatic mutations are efficiently selected by antigen resulting in affinity maturation of the immune response. In case of recurrent or prolonged antigenic stimulation, the extent to which somatic mutations lead to higher binding affinity in an already sdected B call done becomes limited and finally saturated. At this point, persistent antigenic stimulation may result in the accumulation of "neutral" R and S mutations, i.e., mutations that do not affect the affinity or the structural integrity of the Ig molecule. Such mutations are not selected for or against, and may shift the R/S ratio towards a pattern resembling random mutations. It may be envisaged that such a pattern of mutations of V regions is associated with antigens that chronically and/or recurrently stimulate the immune system, as is the case with allergens and perhaps particular autoantigens (22) . In the above scenario, mutations continue to occur in secondary and higher order immune responses as a result of repeated or chronic exposure to the same antigen. Four out of seven e V.5 sequences from patient P2 were donally related as judged by their junctional regions. This set of sequences contained, in addition to many shared somatic mutations, at least three unique mutations. These numbers represent a minimum estimate because somatic mutations in the DR and JR segments were not included in our analysis. We constructed a genealogical tree based on the premise that the most shared mutations were acquired early, and the least shared mutations were acquired late in the evolution of the done. Indeed, the general pattern of mutations appears to reflect the temporal order of somatic mutations acquired during expansion of the done (17, 26) . A small number of shared mutations in the clonally related set of e transcripts likely arose as a result of parallel events (i.e., the A-*T at position 17 and the A--~G at position 127; Fig. 1 ).
It has been previously reported that the V regions of murine hybridomas secreting monodonal antihapten antibodies share somatic mutations, even among hybridomas from different mice and generated in different laboratories (27, 28) . In addition, shared mutations have been noted in hybridomas carrying "passenger" transgenes that are not functionally expressed (29, 30) . Shared R mutations have been interpreted to reflect the influence of antigen sdection conferring proliferative advantage to the B cell clone, whereas shared S mutations may mark positions that are especially prone to somatic mutation, so-called hot spots (28, 31) . In the collection of 19 e V.5 transcripts, we found a remarkably high incidence of shared mutations, even among transcripts derived from different germline members of the V.5 gene family. The shared mutations were distributed over CDR and FR regions and included both S and R mutations. In the current anal-)'sis, it can be excluded that these mutations represent artifacts introduced, for example, as a consequence of cell fusion or in vitro growth of hybridomas. A high number of mutations in the collection of e V.5 transcripts was also found in two V.5 expressed genes reported by Andris et al. (32) . Thus, out of 17 mutations present in a V.5 gene encoding an anti-HIV antibody, 12 are also present in the same position in at least one but often multiple e VH5 transcripts, seven of which constitute identical substitutions (32) . Similarly, the majority of mutations present in the V,5 genes encoding an antiinsulin autoantibody and an antirabies virus antiidiotypic antibody also appear in multiple independent e V.5 transcripts (33) . Thus, the seemingly unprobable event of isolating multiple parallel somatic alterations in V. transcripts from unrelated individuals and in antibodies with different specificities constitutes, in fact, a frequently occurring phenomenon.
The molecular basis for the high incidence of shared mutations remains to be elucidated. Based on thdr diversity, multitude, and distribution pattern in the collection of e V,5 transcripts, it seems unlikely that a somatic gene conversion mechanism, even when considering multiple segmental exchanges, is a major contributor (34) . Rather, the accumulation of point mutations, perhaps in combination with intrinsic sequence specificity of the somatic hypermutation mechanism, constitutes the mechanism underlying shared mutations (30) . In addition, selection by antigen probably contributes to the occurrence of shared R mutations. Although we have not addressed the antigen specificity of the IgE antibodies encoded by these transcripts, it seems unlikely that they all bind to the same epitope.
